@inproceedings{inproceedings, title  = {{Abstract OT2-01-11: A phase 2 randomized, double-blind, placebo-controlled trial of radium-223 dichloride with exemestane and everolimus in human epidermal growth factor receptor 2–negative, hormone receptor–positive breast cancer patients with bone metastases}},

 publisher = {{American Association for Cancer Research}},

 url = {{}},

 year = {{2016}},

 month = {{2}},

 author = {{Rugo HS and Huang L and Petrenciuc O and Zaccarini P and Coleman RE}},

 doi = {{10.1158/1538-7445.sabcs15-ot2-01-11}},

 journal = {{Ongoing Clinical Trials}},

 note = {{Accessed on 2025/10/10}}}